Cross-institution positioning
Aug 6, 2026Strong institutional reduction. 1 accumulating, 2 reducing, 2 exited across 5 comparable institutions.
Source: Schedule 13 researchCSTM Institutional Ownership
CONSTELLIUM SE
Latest stored close $25.60 as of Oct 8, 2026 View live quote ↗
STOCKNODE Outlook
Neutral
40/100
5 tracked · 5 comparable
Latest filing
Aug 6, 2026
Positive breadth
1 positive · 4 negative
Recent close
$25.60
Research confidence
Medium
Institutional Research 16/100 · 1 accumulating · 4 reducing / exited
Ownership history
Reported ownership % history
Latest filing Aug 6, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating1
Newly reported0
Reducing / exited
4
52-week position
—
Institutional Intelligence
Why STOCKNODE says Neutral
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Neutral 40/100
Confidence:Medium
Why this signal
- 1 tracked institution accumulating versus 4 reducing/exited.
- 1 tracked institution recently reversed from reducing to accumulating.
- Comparable SEC fundamentals are improving.
Conflicting evidence
- Institutions are reducing while comparable SEC fundamentals are improving.
Institutional
25/100
Insiders
59/100
Fundamentals
70/100
Events
50/100
Quarterly 13F activity
Jun 30, 20261 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Aug 3, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 1 purchase by 1 reporting owner and 0 sales by 0 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Jul 29, 20261 non-amendment material event in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Apr 29, 2026Revenue +24.4% YoY; Net income +437.8% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 49% through its reported 52-week range; +68.7% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from Fidelity / FMR.
Filed Aug 6, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Aug 6, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
BlackRock
Filed Jul 17, 2025
Direction locked
T. Rowe Price Investment Management
Filed Sep 8, 2025
Direction locked
BlackRock
Filed Feb 6, 2024
Direction locked
Fidelity / FMR
Filed Aug 6, 2026
Direction locked
T. Rowe Price Associates
Filed Aug 10, 2022
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
BlackRock
Filed Jul 17, 2025
T. Rowe Price Investment Management
Filed Sep 8, 2025
BlackRock
Filed Feb 6, 2024
Fidelity / FMR
Filed Aug 6, 2026
T. Rowe Price Associates
Filed Aug 10, 2022
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales00 reporting owner(s)
90-day purchase breadth1
90-day sale breadth0
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Deslarzes Jean-Christophe | POpen-market or private purchase | Ordinary shares | 1.5K | $27.24 | Direct | Aug 3, 2026 |
| Jul 10, 2026 | Joerg Ingrid | FTax/price withholding or payment | Ordinary shares | 3.0K | $29.28 | Direct | Jul 13, 2026 |
| Jun 4, 2026 | Ormerod John | SOpen-market or private sale | Ordinary shares | 8.0K | $35.01 | Direct | Jun 8, 2026 |
| May 28, 2026 | Becker Marcus | SOpen-market or private sale | Ordinary shares | 10.4K | $34.93 | Direct | Jun 1, 2026 |
| May 14, 2026 | Soultz Bradley Lee | POpen-market or private purchase | Ordinary shares | 2.5K | $33.84 | Indirect | May 18, 2026 |
| May 14, 2026 | Jarrett Martin | SOpen-market or private sale | Ordinary shares | 4.7K | $33.46 | Direct | May 18, 2026 |
| May 12, 2026 | Piquier Ludovic | SOpen-market or private sale | Ordinary shares | 1.0K | $33.57 | Direct | May 13, 2026 |
| May 11, 2026 | Brun Nicolas | SOpen-market or private sale | Ordinary shares | 26.7K | $33.85 | Direct | May 12, 2026 |
| May 8, 2026 | Corre Stephane | SOpen-market or private sale | Ordinary shares | 5.0K | $33.52 | Direct | May 12, 2026 |
| May 5, 2026 | Brandjes Michiel | SOpen-market or private sale | Ordinary shares | 10.4K | $31.25 | Direct | May 7, 2026 |
| May 5, 2026 | Guo Jack Q. | SOpen-market or private sale | Ordinary shares | 25.2K | $32.62 | Direct | May 7, 2026 |
| May 1, 2026 | Hoffmann Philippe | SOpen-market or private sale | Ordinary shares | 50.0K | $31.92 | Direct | May 5, 2026 |
| May 1, 2026 | Jurkovic Philip Ryan | SOpen-market or private sale | Ordinary shares | 48.8K | $32.01 | Direct | May 4, 2026 |
| May 1, 2026 | Corre Stephane | SOpen-market or private sale | Ordinary shares | 5.0K | $32.04 | Direct | May 4, 2026 |
| May 1, 2026 | Deslarzes Jean-Christophe | POpen-market or private purchase | Ordinary shares | 1.3K | $31.13 | Direct | May 1, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events0
90-day capital-related0
90-day equity-related0
90-day debt-related0
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Jul 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jun 24, 2026 | S-3ASR | — | Shelf securities registration | Capital-related | Filing |
| May 21, 2026 | 8-K | 5.07, 9.01 | Shareholder vote results; Financial statements / exhibits | — | Filing |
| Apr 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 12, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Feb 18, 2026 | 8-K | 2.02 | Results of operations / financial condition | — | Filing |
| Oct 29, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Oct 29, 2025 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$2.5B
Q1 2026
+24.4% YoY 10-Q filed Apr 29, 2026
Net income
$199.0M
Q1 2026
+437.8% YoY 10-Q filed Apr 29, 2026
Diluted EPS
$1.42
Q1 2026
+446.2% YoY 10-Q filed Apr 29, 2026
Operating cash flow
$73.0M
Q1 2026
+25.9% YoY 10-Q filed Apr 29, 2026
Free cash flow
$1.0M
Q1 2026
+109.1% YoY 10-Q filed Apr 29, 2026
Cash & equivalents
$143.0M
As of Mar 31, 2026
+21.2% YoY 10-Q filed Apr 29, 2026
Assets
$5.8B
As of Mar 31, 2026
+13.1% YoY 10-Q filed Apr 29, 2026
Liabilities
$4.7B
As of Mar 31, 2026
+7.0% YoY 10-Q filed Apr 29, 2026
Stockholders’ equity
$1.1B
As of Mar 31, 2026
+50.2% YoY 10-Q filed Apr 29, 2026
Shares outstanding
136.2M
As of Mar 31, 2026
-4.7% YoY 10-Q filed Apr 29, 2026
View recent revenue trend
Quarterly
| Period | Revenue | YoY |
|---|---|---|
| Ended Mar 31, 2026 | $2.5B | +24.4% |
| Ended Sep 30, 2025 | $2.2B | +20.2% |
| Ended Jun 30, 2025 | $2.1B | +8.9% |
| Ended Mar 31, 2025 | $2.0B | +5.3% |
Annual
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $8.4B | +15.2% |
| Ended Dec 31, 2024 | $7.3B | -6.3% |
| Ended Dec 31, 2023 | $7.8B | -8.3% |
| Ended Dec 31, 2022 | $8.5B | — |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$25.57
View live quote ↗
52-week low
$14.39
Oct 10, 2025
52-week high
$36.99
Jun 2, 2026
Below 52-week high
30.9%
1W return
-7.0%
1M return
-13.6%
3M return
-26.3%
6M return
+3.9%
YTD return
+35.6%
1Y return
+68.7%
30-day volatility
39.9%
90-day volatility
43.9%
1Y max drawdown
-30.0%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 26 filing(s) · 23 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Aug 6, 2026 filed · 37d Schedule 13G amendment | Exit below reporting threshold | 2.2K -4.8K | 1.60% -10.40 pts | $31.87 | $28.61 | $25.60 |
| Fidelity / FMR CIK0000315066 | Mar 31, 2026 observed May 6, 2026 filed · 36d Schedule 13G amendment | Reported reduction | 7.0K -10.6M | 12.00% +4.30 pts | $24.58 | $33.33 | $25.60 |
| Fidelity / FMR CIK0000315066 | Dec 31, 2025 observed Feb 5, 2026 filed · 36d Schedule 13G amendment | Reported reduction | 10.6M -4.1M | 7.70% -2.27 pts | $18.85 | $23.35 | $25.60 |
Explore more institutional activity
Related research
Compare CSTM with other securities showing similar institutional activity or recent accumulation across several tracked institutions.